Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma (Q44771284)
Jump to navigation
Jump to search
scientific article published on 11 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma |
scientific article published on 11 April 2011 |
Statements
1 reference
Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma (English)
1 reference
Taiji Tsukamoto
1 reference
Seiji Naito
1 reference
Masaru Murai
1 reference
Koichi Fukino
1 reference
Hideyuki Akaza
1 reference
11 April 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference